Friday, February 3, 2023
  • About Us
  • Contact Us
UAE247.CLUB
No Result
View All Result
SUBMIT NEWS
  • Home
  • Arts
  • Business
  • Entertainment
  • Health
  • Real Estate
  • Tech
  • Travel
  • Middle East
  • Press Releases
  • Home
  • Arts
  • Business
  • Entertainment
  • Health
  • Real Estate
  • Tech
  • Travel
  • Middle East
  • Press Releases
SUBMIT NEWS
No Result
View All Result
Writy.
Submit PR
Plasma Fractionation Market worth $36.7 billion by 2027

Plasma Fractionation Market worth $36.7 billion by 2027

Newsroom Editor by Newsroom Editor
November 18, 2022
in Press Releases
Share on FacebookShare on Twitter


 


(EMAILWIRE.COM, November 18, 2022 )

The global Plasma Fractionation Market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7%.

Major Growth Driving Factors:

The growing use of immunoglobulins in various off-label indication and growing genetic research for characterizing and diagnosing immunodeficiency resulting in increased application of plasma fractionation products, growing geriatric population such as the population of people above 60 age expected to reach 2.1 billion by 2050, increased use of protease inhibitors such as alpha-1-antitrypsin for the treatment of lung diseases, and increased incidence of communicable diseases are the major factors driving the growth of this market.

In 2021, the IVIG segment accounted for the largest share of the Immunoglobulins market

Based on immunoglobulins, the plasma fractionation market is segmented into into intravenous, subcutaneous, and other immunoglobulins. IVIG accounted for the largest share of the global Immunoglobulins market in 2021. The large share of this segment is primarily attributed to its use across various disease such as on label and off lable indiacations such as dermatomyositis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), immune cytopenias, hypogammaglobinemia, primary antibody deficiency, vacuities, multiple sclerosis, asthma, and systemic lupus erythematosus, among other ailments. Also the shorter rapid response period of IVIG than steroids or oral immunosuppressants, the increasing investments in healthcare and the rising number of patients suffering from autoimmune diseases and other pathological conditions is key for the growth of this market segment.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93798284

The pulmonology segment is expected to grow at the highest CAGR during the forecast period

Based on application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2021, the pulmonology segment is expected to register the highest CAGR during the forecast period. Growth in this market segment is driven largely significantly increased use of protease inhibitors, such as alpha-1-antitrypsin in recent years. Also, with the rising geriatric population, the prevalence of AATD and COPD is expected to increase across the globe. With the rising incidence of target diseases, the demand for plasma-derived alpha-1-antitrypsin is expected to increase in the coming years making the pulmonogly segment the fastest growing during the forecast period.

Geographical Growth Dynamics:

North America was the largest regional market for plasma fractionation market in 2021

The global plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the innovations in manufacturing processes such as presence of advanced virus removal technologies (such as nanofiltration), and the development of newer plasma products such as ceruloplasmin and IgA, high number of registered hemophilic patients and largest number of plasma collection center. However, the market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growth in increasing number of hemophilic patients, as well as factors such as the increasing number of organ transplantations, modified regulations and monitoring of the implementation of procedures, policies, and guidelines to promote innovation and commercialization, increasing awareness about technologically advanced products in the region, and the improving standard of living across several APAC countries.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=93798284

Key Players:

The plasma fractionation market is an oligopolistic market. The prominent players operating in this market include CSL (Australia), Grifols, S.A. (Spain), Shire (US), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), LFB (France), Biotest AG (Germany), Sanquin (Netherlands), China Biologic Products Holdings Inc. (China), GC Pharma (Korea), Bio Products Ltd. (UK), Japan Blood Products Organization (Japan), Emergent BioSolutions (US), Shanghai Raas Blood Products Co., Ltd. (China), Intas Pharmaceuticals Ltd. (India), Bharat Serum Vaccines Limited (India).

Read More About Related Topics:

Hematology Analyzers and Reagents Market – Global Future Forecasts to 2025

Biosimilars Market – Global Future Forecasts to 2026

Apheresis Market – Global Future Forecasts to 2025

Hemostasis Analyzer Market – Global Future Forecasts to 2025

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Source link

Previous Post

فودافون مصر تتعاون مع اس بي اس مصر لتقديم حلول الفاتورة الإلكترونية عن طريق منصة V-HUB

Next Post

Berg Money is bringing SME payments platform to the UAE

Related News

Bioink Market is expected to grow at a CAGR of 20.48 percent during the forecast period

by Newsroom Editor
January 27, 2023

(EMAILWIRE.COM, January 27, 2023 ) As per the Maximize Market research, a global business and consultancy firm, the global “Bioink...

Methyl Palmitate Market is expected to grow at a CAGR of 5.2 percent during the forecast period

by Newsroom Editor
January 27, 2023

(EMAILWIRE.COM, January 27, 2023 ) As per the Maximize Market research, a global business and consultancy firm, the global Methyl...

Bio-based Polyurethane Foam Market is expected to grow at a CAGR of 5.9 percent during the forecast period.

by Newsroom Editor
January 27, 2023

(EMAILWIRE.COM, January 27, 2023 ) As per the Maximize Market research, a global business and consultancy firm, the global Bio-based...

NOWA outlines 16 major achievements of Hajiya Aisha Gambo in 2 Years

by Newsroom Editor
January 27, 2023

(EMAILWIRE.COM, January 27, 2023 ) ABUJA, NIGERIA - (ARAB NEWSWIRE) - Hajiya Nana Aisha Gambo is the wife of the...

Next Post
Berg Money is bringing SME payments platform to the UAE

Berg Money is bringing SME payments platform to the UAE

UAE247.Club™ publishes and aggregates business, socio-economic, Tech and industrial news on UAE, Middle East and North Africa (MENA).

Press release distribution services
We provide press release distribution to media in United Arab Emirates, the Arab world and the GCC/MENA regions. Submit a press release today or contact us.

Latest News

Recent Posts
  • Dark arts and intensity: why Howe’s Newcastle are so hard to score against – The Guardian
  • From Abu Dhabi to the world, why the emirate is a global centre of music – The National
  • Timeframe: Three decades of the Sharjah Biennial – The National
  • Audition for MISS SAIGON at White Plains Performing Arts Center in … – Broadway World

Category

Arts
Business
Entertainment
Health
Real State
Tech
Travel
Middle East
Press Releases

Subscribe to Our Newsletter

    UAE247.CLUB™ is part of GroupWeb Media Network. © 2023 GroupWeb Media LLC

    Submit News / About Us / Contact Us
    No Result
    View All Result
    • Home
    • Arts
    • Business
    • Entertainment
    • Health
    • Middle East
    • Press Releases
    • Real Estate
    • Tech
    • Travel
    • About Us
      • Submit a Press Release
      • Contact Us

    UAE247.CLUB™ is part of GroupWeb Media Network. © 2023 GroupWeb Media LLC